# MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II)

> **NCT06879886** · — · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 181 (estimated)

## Conditions studied

- Colorectal Cancer (CRC)
- Colorectal Cancer Liver Metastases (CRLM)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06879886
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-03-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 181 (ESTIMATED)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06879886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06879886, "MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06879886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*